fucose has been researched along with Hemorrhagic Fever, Ebola in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bohorova, N; Hiatt, A; Kim, D; Ngo, L; Olinger, GG; Pauly, M; Pettitt, J; Scully, C; Steinkellner, H; Whaley, KJ; Zeitlin, L | 1 |
1 other study(ies) available for fucose and Hemorrhagic Fever, Ebola
Article | Year |
---|---|
Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.
Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Complement C1q; Ebolavirus; Female; Fucose; Glycosylation; Hemorrhagic Fever, Ebola; Humans; Immune System; Immunization, Passive; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Nicotiana; Surface Plasmon Resonance | 2011 |